When CVS made the decision to forego tobacco sales, the estimated $2 billion in annual revenues it gave up amounts to more than twice the amount of money ACS collects in a year (The Cancer Letter, Feb. 7). However, ACS positions itself as the vanguard of tobacco control, and critics say that close association with a retailer that profits from tobacco undermines the society’s own goals and harms its brand.
The NCI Human Tumor Atlas Network (HTAN) has published a cluster of papers intended to advance the framework of spatial omics, the science of profiling morphological and molecular features of human cancers in two and three dimensions.
